PIK3CA and breast cancer: Concomitant basal and luminal cytokeratin expression has also been observed in a luminal breast cancer model where the MMTV promoter has been used to drive mutant PIK3CA H1047R oncogene expression [52], and one of the pathways activated by PyMT is the PI3K pathway [53], suggesting that similar mechanisms are involved.